194 related articles for article (PubMed ID: 29408284)
1. Family planning providers' role in offering PrEP to women.
Seidman D; Weber S; Carlson K; Witt J
Contraception; 2018 Jun; 97(6):467-470. PubMed ID: 29408284
[TBL] [Abstract][Full Text] [Related]
2. Pre-exposure prophylaxis to prevent HIV infection: current status, future opportunities and challenges.
Krakower DS; Mayer KH
Drugs; 2015 Feb; 75(3):243-51. PubMed ID: 25673022
[TBL] [Abstract][Full Text] [Related]
3. Pre-Exposure Prophylaxis for HIV Prevention in Women: Current Status and Future Directions.
Hodges-Mameletzis I; Fonner VA; Dalal S; Mugo N; Msimanga-Radebe B; Baggaley R
Drugs; 2019 Aug; 79(12):1263-1276. PubMed ID: 31309457
[TBL] [Abstract][Full Text] [Related]
4. United States family planning providers' knowledge of and attitudes towards preexposure prophylaxis for HIV prevention: a national survey.
Seidman D; Carlson K; Weber S; Witt J; Kelly PJ
Contraception; 2016 May; 93(5):463-9. PubMed ID: 26772906
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.
Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Doré V; Meyer L;
Lancet HIV; 2017 Sep; 4(9):e402-e410. PubMed ID: 28747274
[TBL] [Abstract][Full Text] [Related]
6. Integrating Preexposure Prophylaxis for Human Immunodeficiency Virus Prevention Into Women's Health Care in the United States.
Seidman D; Weber S
Obstet Gynecol; 2016 Jul; 128(1):37-43. PubMed ID: 27275793
[TBL] [Abstract][Full Text] [Related]
7. Integrating HIV Pre-Exposure Prophylaxis into Family Planning Care: A RE-AIM Framework Evaluation.
Brant AR; Dhillon P; Hull S; Coleman M; Ye PP; Lotke PS; Folan J; Scott RK
AIDS Patient Care STDS; 2020 Jun; 34(6):259-266. PubMed ID: 32484743
[TBL] [Abstract][Full Text] [Related]
8. Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial.
Bekker LG; Roux S; Sebastien E; Yola N; Amico KR; Hughes JP; Marzinke MA; Hendrix CW; Anderson PL; Elharrar V; Stirratt M; Rooney JF; Piwowar-Manning E; Eshleman SH; McKinstry L; Li M; Dye BJ; Grant RM;
Lancet HIV; 2018 Feb; 5(2):e68-e78. PubMed ID: 28986029
[TBL] [Abstract][Full Text] [Related]
9. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
[TBL] [Abstract][Full Text] [Related]
10. Daily or on-demand oral tenofovir disoproxil fumarate/emtricitabine for HIV pre-exposure prophylaxis: experience from a hospital-based clinic in France.
Noret M; Balavoine S; Pintado C; Siguier M; Brun A; Bauer R; Loze B; Leplatois A; Aslan A; Moudachirou K; Delaugerre C; Rozenbaum W; Molina JM
AIDS; 2018 Sep; 32(15):2161-2169. PubMed ID: 30212403
[TBL] [Abstract][Full Text] [Related]
11. Integrated provision of topical pre-exposure prophylaxis in routine family planning services in South Africa: a non-inferiority randomized controlled trial.
Mansoor LE; Yende-Zuma N; Baxter C; Mngadi KT; Dawood H; Gengiah TN; Samsunder N; Schwartz JL; Doncel GF; Abdool Karim Q
J Int AIDS Soc; 2019 Sep; 22(9):e25381. PubMed ID: 31507088
[TBL] [Abstract][Full Text] [Related]
12. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J
BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439
[TBL] [Abstract][Full Text] [Related]
13. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.
Deutsch MB; Glidden DV; Sevelius J; Keatley J; McMahan V; Guanira J; Kallas EG; Chariyalertsak S; Grant RM;
Lancet HIV; 2015 Dec; 2(12):e512-9. PubMed ID: 26614965
[TBL] [Abstract][Full Text] [Related]
14. Same-day prescribing of daily oral pre-exposure prophylaxis for HIV prevention.
Rowan SE; Patel RR; Schneider JA; Smith DK
Lancet HIV; 2021 Feb; 8(2):e114-e120. PubMed ID: 33128874
[TBL] [Abstract][Full Text] [Related]
15. Optimizing Delivery of HIV Preexposure Prophylaxis for Women in the United States.
Aaron E; Blum C; Seidman D; Hoyt MJ; Simone J; Sullivan M; Smith DK
AIDS Patient Care STDS; 2018 Jan; 32(1):16-23. PubMed ID: 29323558
[TBL] [Abstract][Full Text] [Related]
16. Implementation Strategies to Increase PrEP Uptake in the South.
Sullivan PS; Mena L; Elopre L; Siegler AJ
Curr HIV/AIDS Rep; 2019 Aug; 16(4):259-269. PubMed ID: 31177363
[TBL] [Abstract][Full Text] [Related]
17. Offering pre-exposure prophylaxis for HIV prevention to pregnant and postpartum women: a clinical approach.
Seidman DL; Weber S; Cohan D
J Int AIDS Soc; 2017 Mar; 20(Suppl 1):21295. PubMed ID: 28361503
[TBL] [Abstract][Full Text] [Related]
18. HIV pre-exposure prophylaxis for female sex workers: ensuring women's family planning needs are not left behind.
Bowring AL; Ampt FH; Schwartz S; Stoové MA; Luchters S; Baral S; Hellard M
J Int AIDS Soc; 2020 Feb; 23(2):e25442. PubMed ID: 32064765
[TBL] [Abstract][Full Text] [Related]
19. Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE.
Vaccher S; Grulich A; McAllister J; Templeton DJ; Bloch M; McNulty A; Holden J; Poynten IM; Prestage G; Zablotska I;
BMJ Open; 2016 Jun; 6(6):e012179. PubMed ID: 27324719
[TBL] [Abstract][Full Text] [Related]
20. The Pre-Exposure Prophylaxis-Stigma Paradox: Learning from Canada's First Wave of PrEP Users.
Grace D; Jollimore J; MacPherson P; Strang MJP; Tan DHS
AIDS Patient Care STDS; 2018 Jan; 32(1):24-30. PubMed ID: 29185801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
